Providers

Professor Mike Loosemore is Lead Consultant in Sport and Exercise Medicine at the Institute of Sport, Exercise and Health. He treats the general public with musculoskeletal and sports injuries and is also working to promote exercise as a preventative intervention and treatment in many medical conditions.

Professor Loosemore is a Lead Sports Physician for the English Institute of Sport, based at ISEH where he treats elite athletes from a wide range of sports; he is currently the Chief Medical Officer for GB Boxing and GB Snow sports.

He has travelled extensively with national squads, accompanying teams to 4 Olympic and 5 Commonwealth Games, World and European Championships. He was the Chief Medical Officer (CMO) for the England Commonwealth Games team in New Delhi 2010 and reprised the role for Glasgow 2014. He was CMO for the GB team at the 2018 Winter Olympics.

Professor Loosemore is active in various fields of sport and exercise medicine research and has published work on various aspects of Sports and Exercise Medicine.

In 2011 he was awarded an honorary doctorate in science for ‘outstanding contribution to sport and exercise medicine’. In 2014 he received the Sir Robert Atkins award for ‘an outstanding contribution to sports medicine’.

He was awarded an MBE for services to Sport and Exercise Medicine in 2018.

Professor Gabra is Co-Founder, Board Member and Chief Scientific Officer at Papyrus Therapeutics Inc; he also hold the position of Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust and is Professor Emeritus in Medical Oncology, Imperial College London.

He has extensive experience of preclinical cancer biology and clinical drug development, having previously been Chief Medical Officer at BerGenBio,Oxford, UK and Vice President in Early Clinical Development at AstraZeneca in Cambridge, UK, concurrently holding the positions of Professor of Medical Oncology at Imperial College London and Honorary Consultant in Medical Oncology at Imperial College Healthcare NHS Trust (since 2003) and Adjunct Professor at the Centre for Cancer Biomarkers at University of Bergen. He was previously Head of Medical Oncology, Director of the Ovarian Cancer Action Research Centre and Head of Imperial College Cancer Clinical Trials Unit, as well as Chief of Service of the West London Gynaecological Cancer Centre at Imperial College London. Prior to that he was Cancer Research UK Clinical Scientist and Honorary Clinical Senior Lecturer/Consultant in Medical Oncology at the CRUK Medical Oncology Unit in the University of Edinburgh.

Prof Gabra is an internationally recognised leader in translational research and gynaecological oncology. His research interests include tumour suppressor genes that regulate receptor tyrosine kinase networks (including AXL), the molecular basis of clinical platinum resistance, and all phases of ovarian cancer clinical research. He is the author of more than 200 peer reviewed publications and patents, with over 15,000 citations associated with his publications.

 .

Kwatsi is the company behind HealthPad.

Kwatsi is an innovative health knowledge network that combines the best of blogging and social networking with a micro transaction marketplace.

Kwatsi launched into public beta at the end of January 2012 with an amazing video library on gynaecologic cancers uploaded by experts, patients and students. Kwatsi has a rapidly growing community of users interested in health, lifestyle, medicine, fitness, nutrition and education. Start discovering, sharing and connecting with people around the world snd join our mission to make knowledge sharing rewarding and universally accessible.